Bercede, Ramon B.
HRN: 15-64-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
CEFTRIAXONE 1G (VIAL)
06/26/2022
07/02/2022
IV
2g
OD
PC >100/hpf
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes